Koshinski Asset Management, Inc. Novavax Inc Transaction History

Koshinski Asset Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 18, 2022	BUY	$18.2 - $76.12 $1,674 - $7,003	92 New	92 $226,000
Q2 2022 Jul 12, 2022	SELL	$36.28 - $75.29 $3,337 - $6,926	-92 Closed	0 $0
Q1 2022 Apr 20, 2022	BUY	$69.73 - $142.9 $6,415 - $13,146	92 New	92 $6.78 Million
Q4 2021 Jan 14, 2022	SELL	$134.56 - $217.97 $1,345 - $2,179	-10 Closed	0 $0
Q3 2021 Oct 12, 2021	BUY	$177.8 - $270.58 $1,778 - $2,705	10 New	10 $2,000

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $629M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Koshinski Asset Management, Inc. with notifications on news.